Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2011-04-05
2011-04-05
Kosack, Joseph R (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C548S541000
Reexamination Certificate
active
07919520
ABSTRACT:
The present invention relates to compounds that inhibit TACE, compositions thereof, and methods of using those compounds and compositions for treating diseases.
REFERENCES:
patent: 6313123 (2001-11-01), Levin et al.
patent: 7485664 (2009-02-01), Bandarage et al.
patent: 96/04242 (1996-02-01), None
patent: 00/44709 (2000-08-01), None
M. L. Moss, et al., Drug Discovery Today, 6, 417-426 (2001), esp. p. 417.
F. C. Nelson, et al., Exp. Opin. Invest. Drugs, 8, 383-392 (1999), esp. p. 383.
R. C. Newton, et al., Ann. Rheum. Dis., 60, iii25-iii32 (2001)), esp. p. iii25.
Ohta et al. “Tumor necrosis factor-alpha (TNF-alpha) converting enzyme contributes to production of TNF-alpha in synovial tissues from patients with rheumatoid arthritis” Journal of Rheumatology, 2001, vol. 28, pp. 1756-1763.
Levin et al., “Acetylenic TACE Inhibitors Part 1. SAR of the Acyclic Sulfonamide Hydroxamates”, Bioorganic Medicinal Chemistry Letters, vol. 13, No. 16, pp. 2799-2803, 2003.
Office Action dated Feb. 15, 2007, in U.S. Appl. No. 10/741,164.
Office Action dated Mar. 8, 2006, in U.S. Appl. No. 10/741,164.
Office Action dated Aug. 17, 2005, in U.S. Appl. No. 10/741,164.
Office Action dated Oct. 17, 2006, in U.S. Appl. No. 10/741,164.
Office Action dated Apr. 13, 2007, in U.S. Appl. No. 10/741,164.
Rao et al., “Novel thiol-based TACE inhibitors: Rational design, synthesis, and SAR of thiol-containing aryl sulfonamides”, Bioorganic Medicinal Chemistry Letters, vol. 17, pp. 2250-2253, (2007).
Bandarage, et al., “Novel thiol-based TACE inhibitors. Part 2: Rational design, synthesis, and SAR of thiol-containing aryl sulfones”, Bioorganic Medicinal Chemistry Letters, vol. 18, pp. 44-48, (2008).
Bandarage Upul
Bhisetti Govinda Rao
Come Jon
Perola Emanuele
Saunders Jeffrey O.
Badia Michael C.
Kosack Joseph R
Vertex Pharmaceuticals Incorporated
LandOfFree
Inhibitors of tace does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Inhibitors of tace, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Inhibitors of tace will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2631873